Indication-specific Drug Pricing - Simple in Theory, Complex in Reality
- PMID: 29763404
Indication-specific Drug Pricing - Simple in Theory, Complex in Reality
Abstract
Varying drug prices by indication could be an important value-based strategy in oncology, where multiple indications are becoming the rule. But will administrative costs offset any benefit? And legal and regulatory obstacles could get in the way.
Keywords: Drug Costs; Health Care Costs; Pharmaceutical Economics; Pharmacoeconomics.